OliX Pharmaceuticals Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6,359	3,883	11,983	4,930	34,337
Short-Term Investments	91,900	-	10,000	53,000	15,000
Trading Asset Securities	34,255	8,531	3,942	3,941	420.68
Cash & Short-Term Investments	132,513	12,414	25,925	61,872	49,757
Cash Growth	967.42%	-52.11%	-58.10%	24.35%	-26.95%
Accounts Receivable	5,127	95.11	3,558	53.23	-
Other Receivables	1,115	907.84	1,419	996.88	272.13
Receivables	6,242	1,003	4,977	1,050	491.49
Inventory	396.71	554.26	468.41	657.17	374.13
Prepaid Expenses	1,566	1,370	244.9	1,367	1,480
Other Current Assets	134.21	192.88	526.86	99	136.92
Total Current Assets	140,851	15,534	32,142	65,046	52,240
Property, Plant & Equipment	50,499	51,385	43,910	37,232	31,525
Long-Term Investments	1,352	1,986	23,481	26,809	0.5
Other Intangible Assets	1,944	1,705	1,981	2,107	2,134
Other Long-Term Assets	719.66	639.62	1,312	1,458	772.05
Total Assets	195,366	71,249	102,825	132,651	86,672
Accrued Expenses	738.78	488.52	465.36	358.62	297.85
Short-Term Debt	644	13,441	-	-	-
Current Portion of Long-Term Debt	3,571	3,572	-	19,230	16,405
Current Portion of Leases	318.3	745.85	1,065	939.87	487.8
Current Income Taxes Payable	2.81	53.77	-	-	-
Other Current Liabilities	16,051	11,759	5,033	19,014	23,174
Total Current Liabilities	21,326	30,060	6,563	39,543	40,365
Long-Term Debt	17,857	21,428	35,362	20,000	20,326
Long-Term Leases	895.92	5.38	2,930	3,826	51.69
Pension & Post-Retirement Benefits	-	414.47	-	-	225.41
Other Long-Term Liabilities	5,208	867.98	7,634	3,080	6,296
Total Liabilities	45,287	52,777	52,489	66,449	67,265
Common Stock	10,095	9,230	8,010	6,852	6,852
Additional Paid-In Capital	323,423	175,533	157,177	151,895	92,908
Retained Earnings	-191,586	-167,785	-122,910	-103,224	-84,303
Comprehensive Income & Other	6,458	871.87	7,141	8,885	3,064
Total Common Equity	148,390	17,849	49,418	64,407	18,521
Minority Interest	699.37	623.76	481.45	295.16	886.27
Shareholders' Equity	150,079	18,473	50,336	66,203	19,407
Total Liabilities & Equity	195,366	71,249	102,825	132,651	86,672
Total Debt	23,287	39,192	39,357	43,996	37,271
Net Cash (Debt)	109,227	-26,778	-13,433	17,876	12,487
Net Cash Growth	-	-	-	43.16%	-76.70%
Net Cash Per Share	5550.61	-1589.87	-930.93	1304.50	912.36
Filing Date Shares Outstanding	20.2	18.46	16.02	13.7	13.7
Total Common Shares Outstanding	20.2	18.46	16.02	13.7	13.7
Working Capital	119,525	-14,526	25,578	25,502	11,874
Book Value Per Share	7347.75	966.92	3084.79	4700.19	1351.59
Tangible Book Value	146,445	16,144	47,437	62,300	16,387
Tangible Book Value Per Share	7251.47	874.55	2961.16	4546.39	1195.84
Land	25,325	25,460	25,740	25,740	25,740
Buildings	22,690	23,033	3,354	3,354	3,354
Machinery	7,659	7,425	6,436	5,518	4,427
Construction In Progress	169.57	-	8,948	1,239	71.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.